Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Equity - Summary of Stock Option Activity (Details)

v3.24.3
Note 7 - Stockholders' Equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Outstanding, options (in shares) 22,474  
Outstanding, weighted average exercise price (in dollars per share) $ 85.5  
Outstanding, remaining term (Year) 9 years 10 months 24 days 9 years 6 months
Outstanding, aggregate intrinsic value   $ 0
Granted, options (in shares) 234,000  
Granted, weighted average exercise price (in dollars per share) $ 2.46  
Exercised, options (in shares) 0  
Exercised, weighted average exercise price (in dollars per share) $ 0  
Cancelled/forfeited, options (in shares) 0  
Cancelled/forfeited, weighted average exercise price (in dollars per share) $ 0  
Expired, options (in shares) 0  
Expired, weighted average exercise price (in dollars per share) $ 0  
Outstanding, options (in shares) 256,474 22,474
Outstanding, weighted average exercise price (in dollars per share) $ 9.74 $ 85.5
Expected to vest, options (in shares) 246,802  
Expected to vest, weighted average exercise price (in dollars per share) $ 6.77  
Expected to vest, remaining term (Year) 9 years 10 months 24 days  
Expected to vest, aggregate intrinsic value $ 0  
Exercisable, options (in shares) 9,672  
Exercisable, weighted average exercise price (in dollars per share) $ 85.5  
Exercisable, remaining term (Year) 8 years 8 months 12 days  
Exercisable, aggregate intrinsic value $ 0